<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2025.1665682</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Long-term dietary restriction changes lipid homeostasis and consequently impairs testosterone production in aged <italic>Wistar</italic> rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sokanovic</surname><given-names>Srdjan</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1981156/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Prvulovic</surname><given-names>Milica</given-names></name>
<uri xlink:href="https://loop.frontiersin.org/people/1727202/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Simeunovic</surname><given-names>Valentina</given-names></name>
<uri xlink:href="https://loop.frontiersin.org/people/3178827/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pracer</surname><given-names>Smilja</given-names></name>
<uri xlink:href="https://loop.frontiersin.org/people/2820790/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mladenovic</surname><given-names>Aleksandra</given-names></name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff><institution>Laboratory for Molecular Neurobiology and Behavior, Department of Neurobiology, Institute for Biological Research &#x201C;Sinisa Stankovic&#x201D;&#x2014;National Institute of the Republic of Serbia, University of Belgrade</institution>, <addr-line>Belgrade</addr-line>, <country>Serbia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0004">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/987822/overview">Ivana &#x0160;arac</ext-link>, Institute for Medical Research, University of Belgrade, Serbia</p></fn>
<fn fn-type="edited-by" id="fn0005">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1662163/overview">Esma Menevse</ext-link>, Sel&#x00E7;uk &#x00DC;niversitesi T&#x0131;p Fak&#x00FC;ltesi Hastanesi, T&#x00FC;rkiye</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3161492/overview">Zhaowei Cai</ext-link>, Zhejiang Chinese Medical University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Srdjan Sokanovic, <email>srdjan.sokanovic@ibiss.bg.ac.rs</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1665682</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Sokanovic, Prvulovic, Simeunovic, Pracer and Mladenovic.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Sokanovic, Prvulovic, Simeunovic, Pracer and Mladenovic</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Testosterone (T) is a central androgen responsible for the maintenance of vegetative and reproductive functions and sexual behavior in males. T is mainly synthesized through the process of testicular steroidogenesis with cholesterol (CHOL) as the initial precursor. It is known that T levels gradually decrease, along with an increase in CHOL, LDL-C, triglycerides (TG), and a decrease in HDL-C in advanced stages of life. Dietary restriction (DR) ameliorates lipid status and raises T levels in obese and overweight men. Here, we investigated whether the beneficial effects of DR on serum lipid status consequently improve T production at advanced stages; therefore, we exposed male <italic>Wistar rats</italic> to long-term DR (LTDR, 18&#x202F;months). We confirmed an age-related decrease in serum T levels, reduced expression of genes and proteins of steroidogenic machinery with a simultaneous increase in serum CHOL, LDL-C, and TG levels. LTDR additionally decreased T synthesis, expression of <italic>Star</italic>/StAR and <italic>Cyp11a1</italic>/CYP11A1, and testicular CHOL levels. At the same time, LTDR reduced serum CHOL, LDL-C, and TG levels and increased HDL-C levels. To confirm that the effects of DR are determined by the duration of the treatment, we also checked the effects of the short-term DR (STDR, 3&#x202F;months) and demonstrated that STDR did not alter T levels and did not affect serum lipids. Our results indicate the importance of sustained systemic lipid homeostasis for T production in advanced life stages and show that the effects of restricted food intake on testicular androgen capacity depend on the duration of DR.</p>
</abstract>
<kwd-group>
<kwd>testosterone</kwd>
<kwd>cholesterol</kwd>
<kwd>LDL-C</kwd>
<kwd>HDL-C</kwd>
<kwd>long-term dietary restriction</kwd>
<kwd>short-term dietary restriction</kwd>
</kwd-group>
<contract-num rid="cn1">451-03-136/2025-03/200007</contract-num>
<contract-sponsor id="cn1">Ministry of Education, Science and Technological Development of the Republic of Serbia<named-content content-type="fundref-id">10.13039/501100004564</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="67"/>
<page-count count="14"/>
<word-count count="8880"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutrition and Metabolism</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Testosterone (T) is a pivotal male androgen responsible for maintenance of numerous physiological functions including spermatogenesis, secondary sexual characteristics (<xref ref-type="bibr" rid="ref1">1</xref>) as well as sexual behavior (<xref ref-type="bibr" rid="ref2">2</xref>). T is primarily synthesized and produced by testes Leydig cells (LCs) through the complex process of steroidogenesis, which involves enzymatic transformation of cholesterol (CHOL) to T. Steroidogenic cells take up CHOL from circulating high- and low-density lipoproteins (HDL-C, LDL-C) (<xref ref-type="bibr" rid="ref3">3</xref>), or synthesize it <italic>de novo</italic> (<xref ref-type="bibr" rid="ref4">4</xref>). In rat Leydig cells, the inner leaflet of the plasma membrane also represents a source of CHOL for steroidogenesis (<xref ref-type="bibr" rid="ref5">5</xref>). The dominant source of CHOL may be species specific, but it is widely accepted that HDL-C represents the main extracellular source of CHOL for steroidogenesis in rodents. The process is mediated by membrane scavenger receptor B1 (SR-B1, SCARB1) (<xref ref-type="bibr" rid="ref6">6</xref>). In the cells, lysosomal acid lipase (LAL), hormone-sensitive neutral lipase (HSL), together with Niemann&#x2013;Pick disease type C1 and 2 (NPC1/2) proteins, account for the formation of free CHOL, making it available for steroidogenesis or (re)esterification by acyl-coenzyme A-cholesterol acyltransferase activity (ACAT/SOAT1) (<xref ref-type="bibr" rid="ref7">7</xref>). During the initial steps of steroidogenesis, a complex protein machinery and its key component, steroidogenic acute regulatory protein (StAR) facilitates import of free CHOL into mitochondria (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref9">9</xref>) where cytochrome P450 side chain cleavage enzyme (P450scc, CYP11A1) catalyzes formation of pregnenolone. Subsequent reactions occur in the endoplasmic reticulum, where 3 beta-hydroxysteroid dehydrogenase (HSD3B) converts pregnenolone to progesterone, and cytochrome P450 family 17 subfamily A member 1 (CYP17A1) transforms progesterone into androstenedione. In the final reaction, 17 beta-hydroxysteroid dehydrogenase (HSD17B) transforms androstenedione to T. The described pathway, known as the &#x0394;<sup>4</sup> steroidogenic pathway, is dominant in rodents (<xref ref-type="bibr" rid="ref10">10</xref>). Testicular steroidogenesis is primarily regulated by the hypothalamic-pituitary-testicular loop and luteinizing hormone-cyclic adenosine monophosphate (LH-cAMP) signaling pathway. In this cascade, hypothalamic gonadotropin-releasing hormone (GnRH) stimulates pituitary gonadotrophs to synthesize and release luteinizing hormone (LH) (<xref ref-type="bibr" rid="ref11">11</xref>), which activates LH receptors (LHR) expressed on the surface of LCs. Activation of the receptors promotes a rise in cAMP, which initiates steroidogenesis (<xref ref-type="bibr" rid="ref12">12</xref>) and inhibits SOAT1 activity, making CHOL available for T synthesis (<xref ref-type="bibr" rid="ref6">6</xref>). Increased circulation levels of T inhibit the loop activity and suppress its production.</p>
<p>Aging is a complex process associated with failure in multiple organ systems (<xref ref-type="bibr" rid="ref13">13</xref>), including changes in T levels and CHOL homeostasis, and a gradual decline in T levels in both humans (<xref ref-type="bibr" rid="ref14">14</xref>) and rats (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>) has been demonstrated. Plenty of data indicate that age-induced impairment in T production is a consequence of impaired functionality of LCs (<xref ref-type="bibr" rid="ref17">17</xref>) rather than alteration in LCs numbers (<xref ref-type="bibr" rid="ref18">18</xref>). Mechanisms responsible for the reduced functionality of aged LCs are far from elucidated, but it is known that aged LCs do not respond properly to LH (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref19">19</xref>), show decreased expression and activity of steroidogenic enzymes (<xref ref-type="bibr" rid="ref17">17</xref>), and weak expression of Insulin-like 3 peptide, its functionality marker (INSL3) (<xref ref-type="bibr" rid="ref15">15</xref>). Regarding age-induced alterations in lipid homeostasis, increased levels of total CHOL, LDL-C, and decreased HDL-C have been documented in humans (<xref ref-type="bibr" rid="ref20">20</xref>). Elevated levels of triglyceride (TG) and CHOL (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref22">22</xref>) with reduced clearance of LDL-C (<xref ref-type="bibr" rid="ref23">23</xref>) have been documented in rats. Advanced age is also accompanied by a frequent appearance of dyslipidemia, a condition characterized by increased levels of plasma TG and LDL-C with decreased levels of HDL-C, which represents major factors for the development of coronary artery disease (CAD) and cardiovascular diseases (CVD) (<xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>Low T levels are associated with both sexual and non-sexual symptoms, which profoundly impact the quality of men&#x2019;s lives. Non-sexual symptoms associated with low T concentrations include the appearance of obesity, type 2 diabetes mellitus, metabolic syndrome, etc. (<xref ref-type="bibr" rid="ref24">24</xref>). In the context of low T levels and disrupted lipid homeostasis, there is a documented association between sub-physiological levels of T and atherogenic lipid formation, which promotes pathogenesis of atherosclerosis and CAD (<xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). Parameter that is highly correlated with low T levels and CAD/CVD appearance is a high TG to HDL-C (TG/HDL-C) ratio. A high TG/HLD-C ratio has been proposed as a suitable parameter for CAD/CVD prediction (<xref ref-type="bibr" rid="ref27">27</xref>), and it is also shown that TG/HLD-C ratio is inversely correlated with testosterone levels in the case of insulin resistance (<xref ref-type="bibr" rid="ref28">28</xref>).</p>
<p>Dietary restriction (DR) is the most effective non-pharmacological intervention that enhances longevity and health span in numerous nonhuman species and generally refers to the reduction of calories without malnutrition (<xref ref-type="bibr" rid="ref29">29</xref>). Numerous animal and clinical studies suggest that DR positively affects age-related neurodegenerative diseases (<xref ref-type="bibr" rid="ref29">29</xref>), animal activity and spatial memory (<xref ref-type="bibr" rid="ref30">30</xref>), metabolic disorders (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>), decreased systolic and diastolic blood pressure, and has a protective effect against atherosclerosis through decrement of total CHOL, LDL-C, TG and increment of HDL-C (<xref ref-type="bibr" rid="ref33">33</xref>). DR showed dual effects on T production with beneficial effects in obese and overweight men, and negative effects in non-obese men (<xref ref-type="bibr" rid="ref24">24</xref>) and rats (<xref ref-type="bibr" rid="ref34 ref35 ref36">34&#x2013;36</xref>). To examine the way DR impacts testicular steroidogenesis in advanced periods of life, we exposed male <italic>Wistar</italic> rats to 18- and 3-month-long DR. The effects of the treatments were assessed based on the T levels in circulation and testicular content, with concomitant lipid status profile. Molecular mechanisms were evaluated based on the expression of the genes and proteins involved in T synthesis as well as CHOL metabolism.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Animals and treatments</title>
<p>Male <italic>Wistar</italic> rats were used in this study (<italic>n</italic>&#x202F;&#x003E;&#x202F;30, 5&#x2013;10 animals per group). All animal handling procedures complied with the EU Directive 2010/63/EU for animal experiments and were approved by the Ethical Committee for the Use of Laboratory Animals of the Institute for Biological Research &#x201C;Sinisa Stankovic&#x201D;&#x2014;The National Institute of the Republic of Serbia, University of Belgrade, and by The National Ethic Research Committee (No. 323-07-13, No. 536/2020-05, No. 05-06/14). Animals were housed in a 12-h light/dark cycle with constant temperature (21&#x202F;&#x00B1;&#x202F;2 &#x00B0;C) and humidity (60&#x2013;70%). Animals were fed with standard laboratory chow (chemical composition presented in the <xref ref-type="table" rid="tab1">Table 1</xref>, manufacturer VZS Stocna hrana d.o.o, Subotica, Serbia) with free access to water. DR treatment used in this study represents a reduction of daily food intake by 40% based on average daily food consumption. This study included two DR regimes: long-term DR (LTDR), started at 6&#x202F;months and lasted up to the 24th month of life (<italic>n</italic>&#x202F;=&#x202F;10), and short-term DR (STDR), started at 21&#x202F;months and lasted up to the 24th month of life (<italic>n</italic>&#x202F;=&#x202F;10); the experiments were repeated two times. Intact 24-month-old males (aged, <italic>n</italic>&#x202F;=&#x202F;10) with no limited access to food were used as controls for LTDR and STDR, the study also included intact 6-month-old males (adults, <italic>n</italic>&#x202F;=&#x202F;5). Animals were regularly weighed and monitored for well-being during the entire study period. At the end of the treatments, animals were euthanized in deep anesthesia using Zoletil 100 (75&#x202F;mg/kg), blood was collected from the heart, and transcardial perfusion with cold saline was performed, and tissues were collected and stored at &#x2212;80 &#x00B0;C. The serum was prepared by centrifuging coagulated blood (300&#x202F;&#x00D7;&#x202F;g/15&#x202F;min/4 &#x00B0;C) and stored at &#x2212;20 &#x00B0;C until analyzing.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Chemical composition of standard laboratory chow.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Ingredient</th>
<th>Quantity</th>
<th>Ingredient</th>
<th>Quantity</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Proteins</td>
<td align="left" valign="top">20%</td>
<td align="left" valign="top">Vitamin A</td>
<td align="left" valign="top">12,000&#x202F;U/kg</td>
</tr>
<tr>
<td align="left" valign="top">Fat</td>
<td align="left" valign="top">5%</td>
<td align="left" valign="top">Vitamin D3</td>
<td align="left" valign="top">2,000&#x202F;U/kg</td>
</tr>
<tr>
<td align="left" valign="top">Humidity</td>
<td align="left" valign="top">11.5%</td>
<td align="left" valign="top">Vitamin E</td>
<td align="left" valign="top">30&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Cellulose</td>
<td align="left" valign="top">5%</td>
<td align="left" valign="top">Vitamin B1</td>
<td align="left" valign="top">4&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Ashes</td>
<td align="left" valign="top">8%</td>
<td align="left" valign="top">Vitamin B2</td>
<td align="left" valign="top">7&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Lysine</td>
<td align="left" valign="top">0.6%</td>
<td align="left" valign="top">Vitamin B6</td>
<td align="left" valign="top">6&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Methionine</td>
<td align="left" valign="top">0.6%</td>
<td align="left" valign="top">Vitamin B12</td>
<td align="left" valign="top">0.05&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Tryptophan</td>
<td align="left" valign="top">0.15%</td>
<td align="left" valign="top">Folic acid</td>
<td align="left" valign="top">1&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Calcium</td>
<td align="left" valign="top">0.95%</td>
<td align="left" valign="top">Choline chloride</td>
<td align="left" valign="top">1,000&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Phosphorus</td>
<td align="left" valign="top">0.7%</td>
<td align="left" valign="top">Niacin</td>
<td align="left" valign="top">20&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Zink</td>
<td align="left" valign="top">30&#x202F;mg/kg</td>
<td align="left" valign="top">Pantothenic acid</td>
<td align="left" valign="top">10&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Copper</td>
<td align="left" valign="top">15&#x202F;mg/kg</td>
<td align="left" valign="top">Antioxidants E-202</td>
<td align="left" valign="top" rowspan="4">125&#x202F;mg/kg</td>
</tr>
<tr>
<td align="left" valign="top">Iron</td>
<td align="left" valign="top">60&#x202F;mg/kg</td>
<td align="left" valign="top">Antioxidants E-320</td>
</tr>
<tr>
<td align="left" valign="top">Magnesium</td>
<td align="left" valign="top">60&#x202F;mg/kg</td>
<td align="left" valign="top">Antioxidants E-321</td>
</tr>
<tr>
<td align="left" valign="top">Iodine</td>
<td align="left" valign="top">0.15&#x202F;mg/kg</td>
<td align="left" valign="top">Antioxidants E-338</td>
</tr>
<tr>
<td align="left" valign="top">Selenium</td>
<td align="left" valign="top">0.3&#x202F;mg/kg</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Serum lipid measurements</title>
<p>To assess serum lipid status, concentrations of CHOL, HDL-C, LDL-C, and TG were measured. All the reagents and standards were obtained from the same manufacturer (BioSystems S.A. Costa Brava, Barcelona, Spain), and measurements were performed according to the manufacturer&#x2019;s instructions<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> using a clinical chemistry analyzer BS-240 (Mindray, Shenzhen, China). Detection limits were: 0.008&#x202F;mmoL/L for CHOL, 0.01&#x202F;mmoL/L for HDL-C, 0.007&#x202F;mmoL/L for LDL-C, 0.018&#x202F;mmoL/L for TG; for all the parameters, intra/inter run variations were &#x003C;5%.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Hormone assays and steroid extraction</title>
<p>Serum hormone levels were determined with appropriate ELISA kits according to the manufacturer&#x2019;s instructions. For corticosterone measurement, we used Enzo corticosterone ELISA kit (ADI-900-097, Enzo Life Science, Farmingtone, NY, United States), and for T measurement, we used Cayman Testosterone ELISA kit (No. 582701, Cayman Chemical, Ann Arbor, MI, United States). To determine T levels in testes, pieces of testes were homogenized with 1&#x202F;&#x00D7;&#x202F;PBS (137&#x202F;mM NaCl, 2.7&#x202F;mM KCl, 10&#x202F;mM Na<sub>2</sub>HPO<sub>4</sub>, 1.8&#x202F;mM KH<sub>2</sub>PO<sub>4</sub>, v/w&#x202F;=&#x202F;10&#x202F;&#x03BC;L/mg) and an equal volume of homogenate was used for steroid extraction by diethyl ether. After evaporation of diethyl ether, the dry pellet was resuspended with ELISA buffer, and T levels were determined by the same ELISA kit (<xref ref-type="bibr" rid="ref15">15</xref>). All the relevant comparisons were made in the same assay; intra-assay variation for corticosterone was &#x003C;10% and for T was &#x003C;15%; minimal detectable hormone concentrations were 32&#x202F;pg/mL and 3.9&#x202F;pg/mL, respectively. To determine levels of testicular CHOL, the same procedure of extraction was applied, the dry pellet was resuspended in 1&#x202F;&#x00D7;&#x202F;PBS enriched with bovine serum albumin fraction V (1&#x202F;&#x00D7;&#x202F;PBS-0.1%-BSA), and CHOL levels were determined according to Biosystems protocol (see text footnote 1) and BS-240 analyzer (Mindray, Shenzhen, China).</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>RNA isolation and qRT-PCR analysis</title>
<p>Total RNA was isolated from pieces of testes, liver, and whole pituitary by Trizol reagent (300&#x202F;&#x03BC;L/sample, Ambion, Austin, TX) with the addition of chloroform (60&#x202F;&#x03BC;L/sample). After shaking and centrifugation (12,000&#x202F;&#x00D7;&#x202F;g/15&#x202F;min/4 &#x00B0;C) supernatant was collected, RNA was extracted by isopropyl alcohol (250&#x202F;&#x03BC;L/sample) and centrifugation (12,000&#x202F;&#x00D7;&#x202F;g/10&#x202F;min/4 &#x00B0;C). Collected RNA was washed twice with 75% ethanol, resuspended in RNase-free water, and DNase I treatment was performed according to Invitrogen manufacturer&#x2019;s protocol.<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> The amount and purity of the total RNA were assessed by spectrophotometric measurement (Nanophotometer N60, Implen, Munchen, Germany), and 1&#x202F;mg of RNA was used for cDNA synthesis. First-strand cDNA was synthesized by High-Capacity cDNA reverse transcription kit<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> according to the manufacturer&#x2019;s instructions. qPCR was performed by Taq-Man Gene- or SYBR Green-based technology (Applied Biotechnology, Waltham, Massachusetts, United States) in the presence of 10&#x202F;ng cDNA using Quant Studio 3 (Applied Biotechnology). Target gene expression levels were determined by the comparative 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> quantification method with <italic>Gapdh</italic> as the reference gene. Used Applied Biosystems predesigned TaqMan Gene Expression Assays: <italic>Abca1</italic> (Rn00710172_m1), <italic>Apob</italic> (01499054_m1), Cyp46a1 (Rn01430187_g1), <italic>Gapdh</italic> (Rn01462662_g1), <italic>Hmgc</italic> (Rn 00565598_m1), <italic>Lrp1</italic> (Rn01503901), <italic>Ldlr</italic> (Rn00598442_m1), <italic>Npc1</italic> (Rn01531821_m1), <italic>Soat1</italic> (Rn_00579605_m1), <italic>Srebf1</italic> (Rn01495769_m1); sequences of used forward and reverse primers are listed in <xref ref-type="supplementary-material" rid="SM3">Supplementary Table 1</xref>.</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Protein isolation and western blot method</title>
<p>Proteins were isolated from the pieces of testes and whole pituitary tissues using Ripa buffer (50&#x202F;mM Tris-HCl, 150&#x202F;mM NaCl, 1% NP-40, 0.1% SDS, 10&#x202F;mM EDTA, 10&#x202F;mM EGTA, 0.5% Triton X-100; V/W&#x202F;=&#x202F;10&#x202F;&#x03BC;L/mg) enriched with protease and phosphatase inhibitor cocktails (Roche, GmbH, Germany). After homogenization, the samples were centrifuged (15,000&#x202F;&#x00D7;&#x202F;g/30&#x202F;min/4 &#x00B0;C), supernatants were collected, and protein concentration measurement and uniformization of the samples were done by Pierce BSA Protein Assay Kit (ThermoFisher Scientific, Waltham, MA, United States). An equal amount of protein (50&#x202F;&#x03BC;g/well) was loaded onto 10&#x2013;15% SDS-polyacrylamide gels and separated by SDS-PAGE electrophoresis (Bio-Rad, Hercules, CA, United States). Transfer of proteins onto nitrocellulose (0.45&#x202F;&#x03BC;m, Amersham, MA, United States) or PVDF (0.2&#x202F;&#x03BC;m, Invitrogen, Waltham, MA, United States) membrane was done by wet transfer (30&#x202F;V/4 &#x00B0;C, overnight) using Bio-Rad system. Membranes were stained with 0.1% Ponceau S (Serva Electrophoresis GmbH, Germany) or Pierce Reversible Protein Stain Kit for nitrocellulose membrane (ThermoFisher Scientific), scanned, and used as the loading control. Destaining was done by 0.1% Tween-TBS (0.05&#x202F;M Tris, 0.15&#x202F;M NaCl, 0.1% Twen; TBST) following membrane blocking with 5% non-fat dry milk (Bio-Rad) in TBST for 2&#x202F;h at room temperature (RT). Membranes were incubated with primary antibodies overnight at 4 &#x00B0;C, multiple washed with TBST, and incubated with horseradish peroxidase conjugated secondary anti-rabbit antibody for 1&#x202F;h/RT. After sufficient washing, chemiluminescent signal was induced by Luminol-H<sub>2</sub>O<sub>2</sub> solution, and immunoblots were visualized using iBright 1500 system (Invitrogen). Quantification of the specific immunoblots, as well as loading control, was performed by Image quant software (version 5.2, GE Healthcare). Used antibodies with dilutions: anti-CYP11A1 antibody (13363-1-AP, Proteintech, Rosemont, IL, United States) 1:1000; anti-LhB antibody (PA5-102674, ThermoFisher Scientific) 1:1,000; anti-StAR antibody (D0H12, Cell Signaling Technology Inc., MA, United States) 1:500; Goat anti-Rabbit antibody (ab205718, Cambridge, United Kingdom) 1:10,000.</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>Statistical analysis</title>
<p>Results represent group mean &#x00B1; SEM values of at least 5 animals per group. Multiple comparison groups were analyzed by one-way ANOVA followed by Tukey&#x2019;s multiple comparison test; comparison between two groups was analyzed by Student&#x2019;s <italic>t</italic>-test or unpaired Mann&#x2013;Whitney nonparametric two-tailed tests; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 was considered statistically significant. GraphPad Prism software (version 6, Dotmatics, MA, United States) was used for mean &#x00B1; SEM values calculations, statistical analysis, and figure generation.</p>
</sec>
</sec>
<sec sec-type="results" id="sec9">
<label>3</label>
<title>Results</title>
<sec id="sec10">
<label>3.1</label>
<title>LTDR changes BW, lipid status, and T levels in aged male <italic>Wistar</italic> rats</title>
<p>As BW, T levels, and lipid homeostasis are tightly connected, we first checked how aging and LTDR affect these parameters. Comparing 6-month-old (adult) and aged males, we observed that aging is accompanied with significant BW gain (adults: 342.5&#x202F;&#x00B1;&#x202F;12.64&#x202F;g; aged: 525&#x202F;&#x00B1;&#x202F;47.87&#x202F;g), and that LTDR abolished this effect (LTDR: 306.0&#x202F;&#x00B1;&#x202F;14.70&#x202F;g; aged: 525&#x202F;&#x00B1;&#x202F;47.87&#x202F;g) preserving BW to the values similar to the BW of adults (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Analyses of lipid status revealed significant alterations in aged animals in comparison to adults: elevated serum levels of CHOL (adults: 1.48&#x202F;&#x00B1;&#x202F;0.10&#x202F;mmoL/L; aged: 2.32&#x202F;&#x00B1;&#x202F;0.15&#x202F;mmoL/L), LDL-C (adults: 0.65&#x202F;&#x00B1;&#x202F;0.05&#x202F;mmoL/L; aged: 1.05&#x202F;&#x00B1;&#x202F;0.14&#x202F;mmoL/L), TG (adults: 0.87&#x202F;&#x00B1;&#x202F;0.14&#x202F;mmoL/L; aged: 1.49&#x202F;&#x00B1;&#x202F;0.14&#x202F;mmoL/L) and TG/HDL-C ratio (adult: 2.45&#x202F;&#x00B1;&#x202F;0.54; aged: 4.15&#x202F;&#x00B1;&#x202F;0.45). In all cases, LTDR effectively normalized levels of examined parameters to the levels detected in adults (CHOL: 1.85&#x202F;&#x00B1;&#x202F;0.08&#x202F;mmoL/L; LDL-C: 0.64&#x202F;&#x00B1;&#x202F;0.03&#x202F;mmoL/L; TG: 0.83&#x202F;&#x00B1;&#x202F;0.12&#x202F;mmoL/L) (<xref ref-type="fig" rid="fig1">Figures 1B</xref>,<xref ref-type="fig" rid="fig1">D&#x2013;F</xref>). In addition, serum HDL-C level that remained unchanged during aging, was significantly increased by LTDR (adults: 0.24&#x202F;&#x00B1;&#x202F;0.04&#x202F;mmoL/L; aged: 0.19&#x202F;&#x00B1;&#x202F;0.03&#x202F;mmoL/L; LTDR: 0.38&#x202F;&#x00B1;&#x202F;0.05&#x202F;mmoL/L) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). As it was expected, aged males had significantly lower levels of serum T, which were additionally decreased by LTDR (adults: 2.012&#x202F;&#x00B1;&#x202F;0.24&#x202F;ng/mL; aged: 0.46&#x202F;&#x00B1;&#x202F;0.11&#x202F;ng/mL; LTDR: 0.10&#x202F;&#x00B1;&#x202F;0.019&#x202F;ng/mL) (<xref ref-type="fig" rid="fig1">Figure 1G</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Effects of the aging and LTDR on the males BW, lipids profile and T levels. 6-month-old (adults), 24-month-old male <italic>Wistar</italic> rats (aged) and males subjected to long-term dietary restriction (18-month-long, 60% of daily food intake, LTDR) were followed to estimate time- and LTDR-induced changes in BW <bold>(A)</bold>. Serum from all the groups was prepared and lipid status was characterized by photometric measurements of CHOL <bold>(B)</bold>, HDL-C <bold>(C)</bold>, LDL-C <bold>(D)</bold> and TG <bold>(E)</bold> levels, and TG/HDL-C ratio was calculated <bold>(F)</bold>. T was determined by ELISA method revealing age induced decrement in T levels with deterioration after LTDR regime <bold>(G)</bold>. The bars shown are mean &#x00B1; SEM values; for all the analysis <italic>n</italic>&#x202F;&#x2265;&#x202F;5; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Seven bar graphs labeled A to G compare different health metrics among Adult, Aged, and LTDR groups. A shows Body Weight, Aged being highest. B depicts Serum Cholesterol, highest in Aged, lower in LTDR. C illustrates Serum HDL-C, with LTDR highest. D shows Serum LDL-C, peaking in Aged, lowest in LTDR. E presents Serum Triglycerides, highest in Aged. F displays TG/HDL-C ratio, Aged highest, LTDR lowest. G shows Serum Testosterone, Adult highest, LTDR lowest. Asterisks and hashtags indicate significant differences.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec11">
<label>3.2</label>
<title>LTDR changes the expression of genes involved in <italic>de novo</italic> synthesis of CHOL and LDL-C metabolism in the liver</title>
<p>To get a better insight into the alterations of the lipid status, we investigated the expression profile of the genes involved in CHOL synthesis, esterification, and transportation. Expression of 3-hydroxy-3-methylglutaryl-CoA reductase (<italic>Hmgcr</italic>, gene for rate-controlling enzyme in CHOL synthesis) was unaffected by aging, but its expression level increased more than twofold following LTDR exposure (adults: 6.85&#x202F;&#x00B1;&#x202F;1.89%; aged: 4.22&#x202F;&#x00B1;&#x202F;0.66%; LTDR: 14.63&#x202F;&#x00B1;&#x202F;2.71%) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Age-induced gene expression was detected in the case of sterol regulatory element binding transcription factor 1 (<italic>Srebf1</italic>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), while age-decreased expression was detected in the case of <italic>Soat1</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Compared to adults, trend of decreased expression of nuclear receptor subfamily 1 group H member 3 (<italic>Lxra</italic>) was recorded in aged animals without effect of LTDR (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Related to LDL mediated CHOL transportation and uptake, expression of <italic>ApoB</italic> was decreased in the aged group and additionally reduced after LTDR (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Expression of gene for LDL receptor (<italic>Ldlr</italic>) was decreased in aged animals, while LTDR reversed its expression to the levels detected in adults (adults: 1.7&#x202F;&#x00B1;&#x202F;0.38%; aged: 0.8&#x202F;&#x00B1;&#x202F;0.13%; LTDR: 1.73&#x202F;&#x00B1;&#x202F;0.13%) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Aging and LTDR did not affect the expression profiles of <italic>ApoA</italic> (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) and <italic>Scarb1</italic>, both involved in HDL mediated CHOL transport and uptake, although a general trend of reduction was observed (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Changes were not detected in the expression profiles of <italic>Npc1</italic> and the gene for LDL receptor-related protein (<italic>Lrp</italic>) (<xref ref-type="fig" rid="fig2">Figures 2I</xref>,<xref ref-type="fig" rid="fig2">J</xref>) involved in intracellular trafficking, and <italic>Abca1</italic> responsible for CHOL efflux (<xref ref-type="fig" rid="fig2">Figure 2K</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>LTDR changed expression of the genes involved in lipid metabolism in the liver. To assess the effects of LTDR on gene expression, pieces of the livers from the adult, aged and LTDR groups were collected, total RNA was extracted, and qPCR was performed. Target gene expression (%) was determined by the comparative 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> quantification method with <italic>Gapdh</italic> as the reference gene. Time- and LTDR-induced changes in expression profile of <italic>Hmgcr</italic>, <italic>Srebf1</italic>, <italic>Soat1</italic>, <italic>Lxra</italic>, <italic>ApoB</italic>, <italic>Ldlr</italic>, <italic>ApoA</italic>, <italic>Scarb1</italic>, <italic>Npc1</italic>, <italic>Lrp</italic>, <italic>Abca1</italic> are presented at panels <bold>A&#x2013;K</bold>. The bars shown are mean &#x00B1; SEM values; for all the analysis <italic>n</italic>&#x202F;&#x2265;&#x202F;5; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs display gene expression levels for Hmgcr, Srebf1, Soat1, Lxra, ApoB, Ldlr, ApoA, Scarb1, Npc1, Lrp, and Abca1. Each graph compares expression across Adult, Aged, and LTDR groups. Notable differences include higher Hmgcr in LTDR, elevated Srebf1 in Aged, and reduced ApoB in Aged and LTDR. Ldlr is lowest in Aged. Statistical significance is indicated with asterisks and hash symbols.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec12">
<label>3.3</label>
<title>LTDR-induced T decrement is not a consequence of disrupted pituitary function</title>
<p>Since low T levels in advanced periods of life may be accompanied by changes in LH levels (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref37">37</xref>), we evaluated if LTDR affected pituitary functionality and gonadotropin synthesis. Gene expression profile and protein abundance of <italic>b</italic> subunits (mediator of biological activity) of LhB were unchanged in advanced periods of life, however, LTDR drastically increased their expression (approximately 3-fold) (<xref ref-type="fig" rid="fig3">Figures 3A</xref>,<xref ref-type="fig" rid="fig3">B</xref>). Expression profile of <italic>Fshb</italic> was unaffected by aging, but approximately twofold increased after the LTDR regime (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Trends of increased expression of alpha polipeptide (<italic>Cga</italic>) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) and trends of decreased expression of <italic>Gnrhr</italic> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) and prolactin (<italic>Prl</italic>) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) were recorded in aged groups. The expression profile of proopiomelanocortin (<italic>Pomc</italic>) was stable in advanced periods of life (<xref ref-type="fig" rid="fig3">Figure 3G</xref>); LTDR had no effects on expression levels of <italic>Cga</italic>, <italic>Gnrhr</italic>, <italic>Prl</italic>, and <italic>Pom</italic>c. Presented results indicate preserved gonadotroph functionality under LTDR, and prompted us to focus our research on the functionality of testes and changed lipid homeostasis.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>LTDR does not alter gonadotrophs function and elevated gonadotropins <italic>b</italic>-subunits expression in the pituitary. Pituitaries from all the groups were collected (<italic>n</italic>&#x202F;=&#x202F;5), total RNA was extracted, and qPCR was performed. Target gene expression (%) was determined by the comparative 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> quantification method with <italic>Gapdh</italic> as the reference gene. Protein abundance was determined by western blot, relative fold of change was calculated based on the intensity of loading content and representative blot is shown. Panels show LTDR inducted expressions of <italic>Lhb</italic>/LhB <bold>(A,B)</bold> and <italic>Fshb</italic> <bold>(C)</bold>. And, expression profiles of <italic>Cga</italic> <bold>(D)</bold>, <italic>Gnrhr</italic> <bold>(E)</bold>, <italic>Prl</italic> <bold>(F)</bold> and <italic>Pomc</italic> <bold>(G)</bold> in advanced periods of life and after the LTDR regime. The bars shown are mean &#x00B1; SEM values; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Graphs display gene expression levels in adult, aged, and LTDR conditions. Panel A shows Lhb expression with increased levels in LTDR. Panel B includes a bar graph and blot for LhB, showing higher expression in LTDR. Panel C shows Fshb expression, also elevated in LTDR. Panel D presents Cga expression, slightly higher in aged. Panel E depicts GnRhr expression, similar across conditions. Panel F shows Prl expression, highest in adults. Panel G displays Pomc expression, comparable across all groups. Bars indicate standard error, with significant differences marked by #.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec13">
<label>3.4</label>
<title>LTDR compromises testis capacity for androgen synthesis</title>
<p>Following reduced serum T levels and preserved gonadotroph functionality after LTDR, we examined testes androgen capacity together with expression of key elements of steroidogenic machinery. According to obtained results, T content in the testes was significantly reduced in aged animals (adult: 1.48&#x202F;&#x00B1;&#x202F;0.26&#x202F;ng; aged: 0.47&#x202F;&#x00B1;&#x202F;0.10&#x202F;ng/10&#x202F;mg tissue) and further decreased by LTDR (0.196&#x202F;&#x00B1;&#x202F;0.02&#x202F;ng) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Compromised androgen capacity under LTDR was followed by unchanged expression of <italic>Lhr</italic> (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) and reduced expression of <italic>Star</italic> (aged: 5.76&#x202F;&#x00B1;&#x202F;0.54%; LTDR: 2.87&#x202F;&#x00B1;&#x202F;0.34%) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) and <italic>Cyp11a1</italic> (aged: 11.74&#x202F;&#x00B1;&#x202F;1.99%; LTDR: 6.59&#x202F;&#x00B1;&#x202F;1.23%) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Age and LTDR induced reduction in gene expression was confirmed by concomitant reduction in proteins (StAR <xref ref-type="fig" rid="fig4">Figure 4D</xref>) and (CYP11A1 <xref ref-type="fig" rid="fig4">Figure 4F</xref>) abundance. All the other examined genes, including <italic>Hsd3b1</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), <italic>Cyp17a1</italic> (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), <italic>Hsd17b3</italic> (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), and <italic>Insl3</italic> (<xref ref-type="fig" rid="fig4">Figure 4J</xref>) showed age-dependent decrease in expression without significant impact of LTDR.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Effects of aging and LTDR on testicular androgen capacity and expression profile of components of testicular steroidogenic machinery. Pieces of testes (<italic>n</italic>&#x202F;=&#x202F;5) were homogenized by 1&#x202F;&#x00D7;&#x202F;PBS (10&#x202F;&#x03BC;L/mg), extraction of steroids was done by ethyl-ether, dry pellet was resuspended in ELISA buffer and T content was determined by ELISA method <bold>(A)</bold>. Total RNA was extracted from pieces of testes (<italic>n</italic>&#x202F;=&#x202F;5&#x2013;6) and qPCR was performed. Expression profiles of <italic>Lhr</italic> <bold>(B)</bold>, <italic>Star</italic> <bold>(C)</bold>, <italic>Cyp11a1</italic> <bold>(E)</bold>, <italic>Hsd3b1</italic> <bold>(G)</bold>, <italic>Cyp17a1</italic> <bold>(H)</bold>, <italic>Hsd17b3</italic> <bold>(I)</bold> and <italic>Insl3</italic> <bold>(J)</bold> are shown. Protein abundance in the testes was determined by western blot, and representative blots of StAR <bold>(D)</bold> CYP11A1 <bold>(F)</bold> are shown. The bars shown are mean &#x00B1; SEM values; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs labeled A to J show gene expression levels and protein changes in adult, aged, and LTDR groups. Each graph indicates differences in expression for various genes such as "Lhr," "Star," and "Cyp11a1." Panels D and F include Western blot images showing protein bands for StAR and CYP11A1, respectively, with Ponceau S and Pierce as loading controls. Asterisks and hashtags denote statistical significance in various comparisons.</alt-text>
</graphic>
</fig>
<p>To better understand processes that mediate LTDR-induced reduction in testes androgen capacity, we checked levels of CHOL in testes together with the expression profiles of genes involved in cholesterol metabolism. Indeed, testicular extracts from the LTDR group contained less CHOL than their <italic>ad libitum</italic> fed, age matched peers (aged: 12.64&#x202F;&#x00B1;&#x202F;2.06; LTDR: 6.89&#x202F;&#x00B1;&#x202F;0.99&#x202F;&#x03BC;g/10&#x202F;mg tissue) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), as well as decreased expression levels of <italic>Ldlr</italic> (aged: 0.55&#x202F;&#x00B1;&#x202F;0.06%; LTDR: 0.38&#x202F;&#x00B1;&#x202F;0.04; <italic>p</italic>&#x202F;=&#x202F;0.038) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Expression of other genes involved in maintaining CHOL homeostasis including <italic>Scarb1</italic>, <italic>Npc1</italic>, <italic>Soat1</italic>, <italic>Hmgcr</italic>, <italic>Srebf1</italic>, <italic>Abca1</italic>, and <italic>Cyp46a1</italic> was not affected by LTDR (<xref ref-type="fig" rid="fig5">Figures 5C</xref>&#x2013;<xref ref-type="fig" rid="fig5">I</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>LTDR regime decreased <italic>Ldlr</italic> expression and CHOL in testes. Testicular tissue (<italic>n</italic>&#x202F;=&#x202F;5&#x2013;8) was homogenized with 1&#x00D7;PBS, extraction of lipids was done by ethyl-ether, dry pellet was resuspended in 0.1%-BSA-1&#x00D7;PBS, and CHOL content was photometrically measured <bold>(A)</bold>. Effects of LTDR on expression of the genes involved in cholesterol metabolism and <italic>de novo</italic> synthesis were assessed with qPCR method, <italic>n</italic>&#x202F;=&#x202F;5 <bold>(B&#x2013;I)</bold>. The bars shown are mean &#x00B1; SEM values; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g005.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs showing the expression levels of various genes related to cholesterol metabolism in testicular tissue. Panel A displays cholesterol levels, while panels B through I show expression of Ldlr, Scarb1, Npc1, Soat1, Hmgcr, Srebf1, Abca1, and Cyp46a1, respectively. Each panel compares "Aged" and "LTDR" groups, with some panels marked with a "#" indicating significant differences.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec14">
<label>3.5</label>
<title>Duration of DR as the main factor of the treatment effects</title>
<p>In the final steps of the study, we checked if the duration of the dietary restriction represents the crucial factor responsible for lipid status alterations and consequently a drop in T levels. To get an answer to this question, we exposed 21-month-old males to the 3-month-long 40%-dietary reduction (STDR) and inspected BW, T production, and lipid profile. Compared to the intact aged group, STDR decreased BW but with less effectiveness than LTDR (aged: 525&#x202F;g&#x202F;&#x00B1;&#x202F;47.87&#x202F;g; STDR 423.8&#x202F;g&#x202F;&#x00B1;&#x202F;12.8&#x202F;g; LTDR: 306.0&#x202F;g&#x202F;&#x00B1;&#x202F;14.70&#x202F;g) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Serum levels of T, CHOL, HDL-C, and LDL-C did not differ significantly between aged and STDR animals (<xref ref-type="fig" rid="fig6">Figures 6B</xref>&#x2013;<xref ref-type="fig" rid="fig6">E</xref>). In line with the presented findings, CHOL and T content in the testes of the STDR group were similar to the content detected in age-matched controls (<xref ref-type="fig" rid="fig6">Figures 6F</xref>,<xref ref-type="fig" rid="fig6">G</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Short-term dietary restriction (STDR) changes BW but does not change T levels and lipid status in advanced periods of life. Aged male <italic>Wistar</italic> rats, males subjected to short-term dietary restriction (3-month-long, 60% of daily food intake, STDR), and males from LTDR group were monitored to estimate the effects of the regimes on the BW <bold>(A)</bold>. Serum levels of T <bold>(B)</bold>, CHOL <bold>(C)</bold>, HDL-C <bold>(D)</bold>, LDL-C <bold>(E)</bold>, as well as testicular levels of CHOL <bold>(F)</bold> and T <bold>(G)</bold> were determined. The bars shown are mean &#x00B1; SEM values; for all the analysis <italic>n</italic>&#x202F;&#x2265;&#x202F;5; <sup>&#x002A;</sup>indicates significant differences compared to aged animals; <sup>#</sup>indicates significant differences compared to the STDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
<graphic xlink:href="fnut-12-1665682-g006.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs comparing aged and differently treated groups: (A) Body weight in grams shows a reduction in STDR and LTDR groups compared to aged. (B) Serum testosterone levels are higher in STDR. (C) Serum cholesterol slightly decreases in STDR. (D) Serum HDL-C levels increase in STDR. (E) Serum LDL-C level decreases in STDR. (F) Testicular cholesterol is similar between aged and STDR. (G) Testicular testosterone levels remain stable between aged and STDR groups. Asterisks and symbols indicate significant differences.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<label>4</label>
<title>Discussion</title>
<p>Aging is a complex process associated with the failure of multiple organ systems, including a decrease in T levels (<xref ref-type="bibr" rid="ref14">14</xref>) and an altered lipid profile (<xref ref-type="bibr" rid="ref20">20</xref>), both of which severely affect quality of life and correlate with a shorter lifespan and increased mortality (<xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref39">39</xref>). Given that the elderly population is constantly growing (<xref ref-type="bibr" rid="ref20">20</xref>), new treatments are needed for androgen deficiency and age-related perturbations in the lipidomic profile, suggesting lipid homeostasis disruption. In terms of reducing the amount of food without malnutrition, DR showed numerous beneficial effects, including normalizing total CHOL, LDL-C, and TG levels and increasing HDL-C levels (<xref ref-type="bibr" rid="ref33">33</xref>). In obese and overweight men, DR significantly improved T levels, and weight loss was declared as the most appropriate intervention for obesity-related hypogonadism (<xref ref-type="bibr" rid="ref40">40</xref>). Given the beneficial effects of DR on lipid status and T production, we wanted to investigate if those effects are related to similar changes in T production at advanced stages of life. We also wanted to investigate whether the duration of DR has any impact on those changes.</p>
<p>Here, we detected an increase in BW, serum CHOL, LDL-C, TG, and TG/HDL-C ratio in advanced stages of life without significant changes in HDL-C levels. LTDR effectively normalized all elevated parameters to the levels seen in adults, but also increased HDL-C levels. These results were expected and have been reported previously (<xref ref-type="bibr" rid="ref33">33</xref>, <xref ref-type="bibr" rid="ref41">41</xref>, <xref ref-type="bibr" rid="ref42">42</xref>). The age-related increase in CHOL, LDL-C, and TG may be attributed to the increased expression of <italic>Srebf1</italic> observed in the liver, as SREBF1 acts as a key transcription factor that can induce lipogenesis and LDL synthesis (<xref ref-type="bibr" rid="ref43">43</xref>, <xref ref-type="bibr" rid="ref44">44</xref>). Since it is known that HMGCR is a master regulator of CHOL <italic>de novo</italic> synthesis and that the expression of <italic>Hmgcr</italic> and <italic>Ldlr</italic> is controlled by a negative loop (<xref ref-type="bibr" rid="ref45">45</xref>, <xref ref-type="bibr" rid="ref46">46</xref>), it is expected that increased expression of these genes will be detected following the LTDR-induced drop in circulating lipids. The drop in serum LDL-C was also accompanied by decreased expression of <italic>ApoB</italic>, and this finding is consistent with the previously published results (<xref ref-type="bibr" rid="ref47">47</xref>); in the same publication, authors also detected an impaired TG synthesis and suppressed <italic>de novo</italic> fatty acid synthesis following DR. Decreased expression of <italic>Lxra</italic> in the liver has been documented in non-alcoholic fatty liver disease (<xref ref-type="bibr" rid="ref48">48</xref>), often seen in the aged population, and a decreased pattern of <italic>Soat1</italic> might be related to dysregulation of cholesterol esters synthesis. Consequently, the results obtained on the expression of <italic>Soat1</italic> and <italic>Lxra</italic> may be suggestive of parameters indicative of disturbed CHOL homeostasis and hepatic functionality during the process of aging. Due to complex relations between changed lipid homeostasis and liver functionality at the latter stages of life, further investigations are needed to elucidate the exact mechanisms promoting age- and DR-induced changes in lipid status.</p>
<p>To check the possibility that LTDR impairs the pituitary function and consequently attenuates T production, the functional status of pituitary cells was examined. Based on the unchanged expression of <italic>Cga</italic>, <italic>Fshb</italic>, and <italic>Lhb</italic> we estimated preserved gonadotrophs functionality in advanced periods of life, which was proposed by earlier studies (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref49">49</xref>). Furthermore, the LTDR-induced increased expression of <italic>Fshb</italic> and <italic>Lhb</italic>/LhB, additionally indicates preserved responsiveness of gonadotrophs (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref50">50</xref>), and most probably is a consequence of reduced T levels and activation of the testicular-pituitary feedback loop. Relatively stable expression of <italic>Gnrhr</italic> after LTDR, suggests that impaired GnRH signaling does not account for decreased T production. As it is known that hyperprolactinemia (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>) and increased activity of the pituitary-adrenal axis (<xref ref-type="bibr" rid="ref53">53</xref>, <xref ref-type="bibr" rid="ref54">54</xref>) disturb gonadotrophs functionality and decrease T production, we inspected the expression profile of <italic>Prl</italic> and <italic>Pomc</italic>. Our results revealed a trend of decreased expression of <italic>Prl</italic> and unchanged expression of <italic>Pomc</italic> following LTDR, and based on these results, we excluded hyperprolactinemia and increased activity of the pituitary-adrenal axis as factors responsible for decreased T production. Considering that fasting or glucose deprivation suppresses pulsatile LH release (<xref ref-type="bibr" rid="ref55">55</xref>), more detailed studies are needed, but at this stage, our findings have led us to focus our research on testicular functionality after LTDR.</p>
<p>Based on the results presented herein, it can be concluded that testicular functionality was significantly impaired during aging, reflected in decreased T content along with reduced expression of key elements of the steroidogenic machinery, including <italic>Lhr</italic>, <italic>Star</italic>/StAR, <italic>Cyp11a1</italic>/CYP11A1, <italic>Hsd3b1</italic>, <italic>Cyp17a1</italic>, <italic>Hsd17b3</italic>, and LCs functional marker <italic>Insl3</italic>. LTDR additionally decreased T content in the testes and the levels of StAR and CYP11A1. These results are in consistency with our previous work (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref49">49</xref>) and relate to age-induced dysfunctionality of LCs rather than their loss (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref50">50</xref>). The reduced androgen capacity induced by reduced food intake has been previously demonstrated in men (<xref ref-type="bibr" rid="ref24">24</xref>) and rats (<xref ref-type="bibr" rid="ref34 ref35 ref36">34&#x2013;36</xref>). More recent studies showed a negative effect of caloric restriction on the testicular metabolome and sperm head formation in rats (<xref ref-type="bibr" rid="ref56">56</xref>) and negative effects of dietary energy restriction on the testicular transcriptome in rams (<xref ref-type="bibr" rid="ref57">57</xref>). To gain better insight into the mechanisms responsible for impaired T synthesis after LTDR, we analyzed testicular CHOL content with concurrent expression profiles of genes involved in CHOL synthesis and transport. Our results pointed to reduced CHOL content and decreased expression of <italic>Ldlr</italic> in the testes of the LTDR group, while the expression profiles of the other genes examined were comparable to those of age-matched controls. Unlike in liver, expression of <italic>Hmgcr</italic> stayed unchanged in testes and point to tissues specific regulation of <italic>Hmgcr</italic> expression and in <italic>de novo synthesis</italic> of CHOL. Difference in <italic>Hmgcr</italic> expression as well as unchanged expression of the genes involved in CHOL <italic>de novo</italic> synthesis and its uptake from HDL-C could be a consequence of impaired LH-cAMP signaling in aged LCs. This opinion comes from the fact that both process are controlled by LH-cAMP signaling in LCs (<xref ref-type="bibr" rid="ref58">58</xref>) and not in liver. Since CHOL is an important precursor for testicular steroidogenesis, the impaired T production in the LTDR group could be a consequence of CHOL deficiency. Since it is known that CHOL needed for steroidogenesis is generated both through endogenously <italic>de novo</italic> synthesis and via circulating lipoproteins (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref59">59</xref>), decreased <italic>Ldlr</italic> gene expression and serum LDL-C levels should be considered as possible cause. Due to the extremely complex regulation of testicular lipid homeostasis, it is difficult to determine the exact source of cholesterol used for testosterone synthesis (<xref ref-type="bibr" rid="ref1">1</xref>). HDL-C has been proposed as the major extracellular source of CHOL for LCs, while LDL-C is also known to support testicular steroidogenesis under certain conditions such as desensitization promoted by hCG/LH (<xref ref-type="bibr" rid="ref60">60</xref>). It is also known that rat HDL contains apolipoprotein E and has a high affinity for LDLR, and presence of HDL with apolipoprotein E increases the T production of rat LCs (<xref ref-type="bibr" rid="ref61">61</xref>). <italic>In vivo</italic> studies showed that simvastatin-treated rats had lower T and LDL-C levels (<xref ref-type="bibr" rid="ref62">62</xref>), while Klinefelter et al. (<xref ref-type="bibr" rid="ref63">63</xref>) demonstrated a statin-induced reduction in LH-stimulated T production in rat LCs. Population studies also showed a positive association between lower LDL-C levels and free T levels (<xref ref-type="bibr" rid="ref64">64</xref>) and a reduction in total T, free T, and LDL-C after statin use (<xref ref-type="bibr" rid="ref65">65</xref>). In the context of impaired LDLR signaling, it has been shown that <italic>ApoE</italic><sup>&#x2212;/&#x2212;</sup><italic>Ldlr</italic><sup>&#x2212;/&#x2212;</sup> mice exhibited reduced T levels, sperm counts, and testicular tubule atrophy (<xref ref-type="bibr" rid="ref66">66</xref>). It has also been shown that low T levels promote the reduction of LDLR and decreased uptake of CHOL in the liver of rats (<xref ref-type="bibr" rid="ref67">67</xref>). Considering that we did not use purified LCs in this study, further mechanistic studies are needed to clarify the role of LDL-C in T production under LTDR. Since LDL-C is known to play a role in the development of atherosclerosis and consequently in inflammation, we excluded the possibility that inflammation in the testis is responsible for LTDR-promoted T reduction based on the expression profile of inflammatory cytokines (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>). Based on serum levels of corticosteroids and the expression of <italic>Nr3c1</italic> and <italic>Hsd11b1/2</italic>, we excluded the involvement of stress in LTDR-mediated T decline (<xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 2</xref>); non-elevated corticosterone levels are consistent with unchanged levels of pituitary expression of <italic>Pomc</italic> in the LTDR group. In contrast to the effects of LTDR, STDR reduced body weight, but to a lesser extent than LTDR, and had no adverse effects on serum and testicular T levels. The treatment also did not alter serum CHOL, HDL-C, LDL-C, and testicular CHOL levels.</p>
<p>In consideration of the results that have been presented, it can be concluded that LTDR, but not STDR, was able to reduce T production at advanced stages of life. Reduced testosterone levels may be a consequence of testicular CHOL deficiency, due to reduced serum CHOL and LDL-C levels after LTDR. The findings reported in this study indicate that the duration of restricted food intake is an essential factor responsible for alterations in lipid homeostasis and compromised androgen capacity of testes. In accordance with the results of this study, which demonstrate the adverse effects of LTDR, it is imperative that individuals practice extreme caution when considering its implementation in the advanced stage of life.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec16">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found in the institutional repository: <ext-link xlink:href="https://radar.ibiss.bg.ac.rs/" ext-link-type="uri">https://radar.ibiss.bg.ac.rs/</ext-link>.</p>
</sec>
<sec sec-type="ethics-statement" id="sec17">
<title>Ethics statement</title>
<p>The animal study was approved by Ethical Committee for the Use of Laboratory Animals of the Institute for Biological Research &#x201C;Sinisa Stankovic&#x201D;&#x2014;The National Institute of the Republic of Serbia, University of Belgrade, and by The National Ethic Research Committee (No. 323-07-13, No. 536/2020-05, No. 05-06/14). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec18">
<title>Author contributions</title>
<p>SS: Conceptualization, Data curation, Investigation, Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. MP: Data curation, Investigation, Methodology, Writing &#x2013; review &#x0026; editing. VS: Data curation, Investigation, Methodology, Writing &#x2013; review &#x0026; editing. SP: Conceptualization, Data curation, Investigation, Methodology, Writing &#x2013; review &#x0026; editing. AM: Conceptualization, Funding acquisition, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec19">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Contract Number 451-03-136/2025-03/200007).</p>
</sec>
<ack>
<p>The results presented in this manuscript are in line with Sustainable Development Goal 3 (Good Health and Well-being) of the United Nations 2030 Agenda. The authors are grateful to Dr. Stanko Stojilkovic (National Institutes of Health, United States) for the kind gift of StAR and CYP11A1 antibodies and to Dr. Bjelobaba Ivana and Dr. Janjic Marija (Institute for Biological Research &#x201C;Sinisa Stankovic&#x201D;) for the kind gift of primers.</p>
</ack>
<sec sec-type="COI-statement" id="sec20">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The handling editor I&#x0160; declared a shared affiliation with the author(s) at the time of review.</p>
</sec>
<sec sec-type="ai-statement" id="sec21">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec22">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec23">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnut.2025.1665682/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnut.2025.1665682/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.TIF" id="SM1" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE 1</label>
<caption>
<p>LTDR does not trigger testicular inflammation and the inflammation-related T reduction. Total RNA was extracted from pieces of testes (<italic>n</italic>&#x202F;=&#x202F;5&#x2013;6), and qPCR was performed. Target gene expression (%) was determined by the comparative 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> quantification method with <italic>Gapdh</italic> as the reference gene. Expression profiles of <italic>Nos2</italic> <bold>(A)</bold>, <italic>Lif</italic> <bold>(B)</bold>, <italic>Il1b</italic> <bold>(C)</bold>, <italic>Il2</italic> <bold>(D)</bold>, <italic>Il6</italic> <bold>(E)</bold>, <italic>Il10</italic> <bold>(F)</bold>, <italic>Tnf</italic> <bold>(G)</bold>, and <italic>Hif1a</italic> <bold>(H)</bold> are shown. The bars shown are mean &#x00B1; SEM values; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.TIF" id="SM2" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE 2</label>
<caption>
<p>Corticosterone and corticosterone-related signaling do not participate in LTDR-induced T reduction. Serum corticosterone was determined by Enzo Corticosterone ELISA kit <bold>(A)</bold>. Total RNA was extracted from pieces of testes, and qPCR was performed. Expression profiles of <italic>Nr3c1</italic> <bold>(B)</bold>, <italic>Hsd11b1</italic> <bold>(C),</bold> and <italic>Hsd11b2</italic> <bold>(D)</bold> are shown. The bars shown are mean &#x00B1; SEM values; for all the analysis <italic>n</italic>&#x202F;=&#x202F;5&#x2013;6; <sup>&#x002A;</sup>indicates significant differences compared to adults; <sup>#</sup>indicates significant differences between aged animals and the LTDR group; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.pdf" id="SM3" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn id="fn0001"><p><sup>1</sup><ext-link xlink:href="http://www.biosystems.global" ext-link-type="uri">www.biosystems.global</ext-link></p></fn>
<fn id="fn0002"><p><sup>2</sup><ext-link xlink:href="http://www.invitrogen.com" ext-link-type="uri">www.invitrogen.com</ext-link></p></fn>
<fn id="fn0003"><p><sup>3</sup><ext-link xlink:href="http://www.fishersci.com" ext-link-type="uri">www.fishersci.com</ext-link></p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name> <name><surname>Chen</surname><given-names>F</given-names></name> <name><surname>Ye</surname><given-names>L</given-names></name> <name><surname>Zirkin</surname><given-names>B</given-names></name> <name><surname>Chen</surname><given-names>H</given-names></name></person-group>. <article-title>Steroidogenesis in Leydig cells: effects of aging and environmental factors</article-title>. <source>Reproduction</source>. (<year>2017</year>) <volume>154</volume>:<fpage>R111</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1530/REP-17-0064</pub-id>, PMID: <pub-id pub-id-type="pmid">28747539</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hull</surname><given-names>EM</given-names></name> <name><surname>Dominguez</surname><given-names>JM</given-names></name></person-group>. <article-title>Sexual behavior in male rodents</article-title>. <source>Horm Behav</source>. (<year>2007</year>) <volume>52</volume>:<fpage>45</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yhbeh.2007.03.030</pub-id>, PMID: <pub-id pub-id-type="pmid">17499249</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gwynne</surname><given-names>JT</given-names></name> <name><surname>Strauss</surname><given-names>JF</given-names></name></person-group>. <article-title>The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands</article-title>. <source>Endocr Rev</source>. (<year>1982</year>) <volume>3</volume>:<fpage>299</fpage>&#x2013;<lpage>329</lpage>. doi: <pub-id pub-id-type="doi">10.1210/edrv-3-3-299</pub-id>, PMID: <pub-id pub-id-type="pmid">6288367</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>FD</given-names></name> <name><surname>Herman</surname><given-names>GE</given-names></name></person-group>. <article-title>Malformation syndromes caused by disorders of cholesterol synthesis</article-title>. <source>J Lipid Res</source>. (<year>2011</year>) <volume>52</volume>:<fpage>6</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1194/jlr.R009548</pub-id>, PMID: <pub-id pub-id-type="pmid">20929975</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venugopal</surname><given-names>S</given-names></name> <name><surname>Martinez-Arguelles</surname><given-names>DB</given-names></name> <name><surname>Chebbi</surname><given-names>S</given-names></name> <name><surname>Hullin-Matsuda</surname><given-names>F</given-names></name> <name><surname>Kobayashi</surname><given-names>T</given-names></name> <name><surname>Papadopoulos</surname><given-names>V</given-names></name></person-group>. <article-title>Plasma membrane origin of the steroidogenic pool of cholesterol used in hormone-induced acute steroid formation in Leydig cells</article-title>. <source>J Biol Chem</source>. (<year>2016</year>) <volume>291</volume>:<fpage>26109</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M116.740928</pub-id>, PMID: <pub-id pub-id-type="pmid">27815506</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>WL</given-names></name></person-group>. <article-title>Steroid hormone synthesis in mitochondria</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2013</year>) <volume>379</volume>:<fpage>62</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mce.2013.04.014</pub-id>, PMID: <pub-id pub-id-type="pmid">23628605</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>FB</given-names></name> <name><surname>Shen</surname><given-names>WJ</given-names></name></person-group>. <article-title>Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis</article-title>. <source>J Lipid Res</source>. (<year>2002</year>) <volume>43</volume>:<fpage>1585</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1194/jlr.r200009-jlr200</pub-id>, PMID: <pub-id pub-id-type="pmid">12364542</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>BJ</given-names></name> <name><surname>Wells</surname><given-names>J</given-names></name> <name><surname>King</surname><given-names>SR</given-names></name> <name><surname>Stocco</surname><given-names>DM</given-names></name></person-group>. <article-title>The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR)</article-title>. <source>J Biol Chem</source>. (<year>1994</year>) <volume>269</volume>:<fpage>28314</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0021-9258(18)46930-x</pub-id>, PMID: <pub-id pub-id-type="pmid">7961770</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Midzak</surname><given-names>AS</given-names></name> <name><surname>Chen</surname><given-names>H</given-names></name> <name><surname>Papadopoulos</surname><given-names>V</given-names></name> <name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group>. <article-title>Leydig cell aging and the mechanisms of reduced testosterone synthesis</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2009</year>) <volume>299</volume>:<fpage>23</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mce.2008.07.016</pub-id>, PMID: <pub-id pub-id-type="pmid">18761053</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>AH</given-names></name> <name><surname>Hales</surname><given-names>DB</given-names></name></person-group>. <article-title>Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones</article-title>. <source>Endocr Rev</source>. (<year>2004</year>) <volume>25</volume>:<fpage>947</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1210/er.2003-0030</pub-id>, PMID: <pub-id pub-id-type="pmid">15583024</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>JC</given-names></name> <name><surname>Kelch</surname><given-names>RP</given-names></name></person-group>. <article-title>Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction</article-title>. <source>N Engl J Med</source>. (<year>1986</year>) <volume>315</volume>:<fpage>1459</fpage>&#x2013;<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJM198612043152306</pub-id>, PMID: <pub-id pub-id-type="pmid">3097540</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dufau</surname><given-names>ML</given-names></name></person-group>. <article-title>The luteinizing hormone receptor</article-title>. <source>Annu Rev Physiol</source>. (<year>1998</year>) <volume>60</volume>:<fpage>461</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.physiol.60.1.461</pub-id>, PMID: <pub-id pub-id-type="pmid">9558473</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>AB</given-names></name> <name><surname>Wittert</surname><given-names>GA</given-names></name></person-group>. <article-title>Endocrinology of the aging male</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source>. (<year>2011</year>) <volume>25</volume>:<fpage>303</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.beem.2010.11.004</pub-id>, PMID: <pub-id pub-id-type="pmid">21397200</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>SM</given-names></name> <name><surname>Metter</surname><given-names>EJ</given-names></name> <name><surname>Tobin</surname><given-names>JD</given-names></name> <name><surname>Pearson</surname><given-names>J</given-names></name> <name><surname>Blackman</surname><given-names>MR</given-names></name></person-group>. <article-title>Longitudinal effects of aging on serum total and free testosterone levels in healthy men</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2001</year>) <volume>86</volume>:<fpage>724</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jcem.86.2.7219</pub-id>, PMID: <pub-id pub-id-type="pmid">11158037</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sokanovic</surname><given-names>SJ</given-names></name> <name><surname>Janjic</surname><given-names>MM</given-names></name> <name><surname>Stojkov</surname><given-names>NJ</given-names></name> <name><surname>Baburski</surname><given-names>AZ</given-names></name> <name><surname>Bjelic</surname><given-names>MM</given-names></name> <name><surname>Andric</surname><given-names>SA</given-names></name> <etal/></person-group>. <article-title>Age related changes of cAMP and MAPK signaling in Leydig cells of Wistar rats</article-title>. <source>Exp Gerontol</source>. (<year>2014</year>) <volume>58</volume>:<fpage>19</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2014.07.004</pub-id>, PMID: <pub-id pub-id-type="pmid">25019473</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zirkin</surname><given-names>BR</given-names></name> <name><surname>Santulli</surname><given-names>R</given-names></name> <name><surname>Strandberg</surname><given-names>JD</given-names></name> <name><surname>Wright</surname><given-names>WW</given-names></name> <name><surname>Ewing</surname><given-names>LL</given-names></name></person-group>. <article-title>Testicular steroidogenesis in the aging brown Norway rat</article-title>. <source>J Androl</source>. (<year>1993</year>) <volume>14</volume>:<fpage>118</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1939-4640.1993.tb01663.x</pub-id>, PMID: <pub-id pub-id-type="pmid">8514617</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name> <name><surname>Hardy</surname><given-names>MP</given-names></name> <name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group>. <article-title>Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH <italic>in vitro</italic></article-title>. <source>Endocrinology</source>. (<year>2002</year>) <volume>143</volume>:<fpage>1637</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1210/endo.143.5.8802</pub-id>, PMID: <pub-id pub-id-type="pmid">11956144</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name> <name><surname>Hardy</surname><given-names>MP</given-names></name> <name><surname>Huhtaniemi</surname><given-names>I</given-names></name> <name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group>. <article-title>Age-related decreased Leydig cell testosterone production in the brown Norway rat</article-title>. <source>J Androl</source>. (<year>1994</year>) <volume>15</volume>:<fpage>551</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1939-4640.1994.tb00498.x</pub-id>, PMID: <pub-id pub-id-type="pmid">7721657</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name> <name><surname>Liu</surname><given-names>J</given-names></name> <name><surname>Luo</surname><given-names>L</given-names></name> <name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group>. <article-title>Dibutyryl cyclic adenosine monophosphate restores the ability of aged Leydig cells to produce testosterone at the high levels characteristic of young cells</article-title>. <source>Endocrinology</source>. (<year>2004</year>) <volume>145</volume>:<fpage>4441</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2004-0639</pub-id>, PMID: <pub-id pub-id-type="pmid">15231695</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HH</given-names></name> <name><surname>Li</surname><given-names>JJ</given-names></name></person-group>. <article-title>Aging and dyslipidemia: a review of potential mechanisms</article-title>. <source>Ageing Res Rev</source>. (<year>2015</year>) <volume>19</volume>:<fpage>43</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2014.12.001</pub-id>, PMID: <pub-id pub-id-type="pmid">25500366</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlile</surname><given-names>SI</given-names></name> <name><surname>Lacko</surname><given-names>AG</given-names></name></person-group>. <article-title>Strain differences in the age related changes of rat lipoprotein metabolism</article-title>. <source>Comp. Biochem. Physiol. B</source>. (<year>1981</year>) <volume>70</volume>:<fpage>753</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0305-0491(81)90012-2</pub-id>, PMID: <pub-id pub-id-type="pmid">24432565</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parini</surname><given-names>P</given-names></name> <name><surname>Angelin</surname><given-names>B</given-names></name> <name><surname>Rudling</surname><given-names>M</given-names></name></person-group>. <article-title>Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>1999</year>) <volume>19</volume>:<fpage>832</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.atv.19.4.832</pub-id>, PMID: <pub-id pub-id-type="pmid">10195906</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>PA</given-names></name> <name><surname>Gibbons</surname><given-names>GF</given-names></name></person-group>. <article-title>Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation</article-title>. <source>Metabolism</source>. (<year>2000</year>) <volume>49</volume>:<fpage>492</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0026-0495(00)80014-1</pub-id>, PMID: <pub-id pub-id-type="pmid">10778874</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SJ</given-names></name> <name><surname>Teo</surname><given-names>SYM</given-names></name> <name><surname>Lopresti</surname><given-names>AL</given-names></name> <name><surname>Heritage</surname><given-names>B</given-names></name> <name><surname>Fairchild</surname><given-names>TJ</given-names></name></person-group>. <article-title>Examining the effects of calorie restriction on testosterone concentrations in men: a systematic review and meta-analysis</article-title>. <source>Nutr Rev</source>. (<year>2022</year>) <volume>80</volume>:<fpage>1222</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nutrit/nuab072</pub-id>, PMID: <pub-id pub-id-type="pmid">34613412</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wickramatilake</surname><given-names>CM</given-names></name> <name><surname>Mohideen</surname><given-names>MR</given-names></name> <name><surname>Pathirana</surname><given-names>C</given-names></name></person-group>. <article-title>Association of serum testosterone with lipid abnormalities in patients with angiographically proven coronary artery disease</article-title>. <source>Indian J Endocrinol Metab</source>. (<year>2013</year>) <volume>17</volume>:<fpage>1061</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.4103/2230-8210.122624</pub-id>, PMID: <pub-id pub-id-type="pmid">24381885</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeap</surname><given-names>BB</given-names></name></person-group>. <article-title>Androgens and cardiovascular disease</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source>. (<year>2010</year>) <volume>17</volume>:<fpage>269</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MED.0b013e3283383031</pub-id>, PMID: <pub-id pub-id-type="pmid">20186051</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosmas</surname><given-names>CE</given-names></name> <name><surname>Rodruguez Palanco</surname><given-names>S</given-names></name></person-group>. <article-title>The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease</article-title>. <source>Diagnostics</source>. (<year>2023</year>) <volume>13</volume>:<fpage>929</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics13050929</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>TH</given-names></name> <name><surname>Kwon</surname><given-names>YJ</given-names></name> <name><surname>Lee</surname><given-names>YJ</given-names></name></person-group>. <article-title>High triglyceride to HDL cholesterol ratio is associated with low testosterone and sex hormone-binding globulin levels in middle-aged and elderly men</article-title>. <source>Aging Male</source>. (<year>2020</year>) <volume>23</volume>:<fpage>93</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13685538.2018.1501015</pub-id>, PMID: <pub-id pub-id-type="pmid">30270690</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>F</given-names></name> <name><surname>Haase</surname><given-names>J</given-names></name> <name><surname>Brandhorst</surname><given-names>S</given-names></name></person-group>. <article-title>The effects of dietary interventions on brain aging and neurological diseases</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>5086</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14235086</pub-id>, PMID: <pub-id pub-id-type="pmid">36501116</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>ST</given-names></name> <name><surname>Smiljanic</surname><given-names>KR</given-names></name> <name><surname>Ruzdijic</surname><given-names>SD</given-names></name> <name><surname>Mladenovic Djordjevic</surname><given-names>A</given-names></name> <name><surname>Kanazir</surname><given-names>SD</given-names></name></person-group>. <article-title>Effects of different dietary protocols on general activity and frailty of male Wistar rats during aging</article-title>. <source>J Gerontol A</source>. (<year>2018</year>) <volume>73</volume>:<fpage>1036</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/gly015</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name> <name><surname>Laferr&#x03B5;re</surname><given-names>B</given-names></name> <name><surname>Thornton</surname><given-names>JC</given-names></name> <name><surname>Pierson</surname><given-names>RN</given-names></name> <name><surname>Pi-Sunyer</surname><given-names>FX</given-names></name></person-group>. <article-title>Regional subcutaneous-fat loss induced by caloric restriction in obese women</article-title>. <source>Obes Res</source>. (<year>2002</year>) <volume>10</volume>:<fpage>885</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1038/oby.2002.121</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J</given-names></name> <name><surname>Keller</surname><given-names>JN</given-names></name></person-group>. <article-title>Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction</article-title>. <source>Aging</source>. (<year>2010</year>) <volume>2</volume>:<fpage>361</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.18632/aging.100155</pub-id>, PMID: <pub-id pub-id-type="pmid">20606248</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>L</given-names></name> <name><surname>Meyer</surname><given-names>TE</given-names></name> <name><surname>Klein</surname><given-names>S</given-names></name> <name><surname>Holloszy</surname><given-names>JO</given-names></name></person-group>. <article-title>Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2004</year>) <volume>101</volume>:<fpage>6659</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0308291101</pub-id>, PMID: <pub-id pub-id-type="pmid">15096581</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chacon</surname><given-names>F</given-names></name> <name><surname>Cano</surname><given-names>P</given-names></name> <name><surname>Jimenez</surname><given-names>V</given-names></name> <name><surname>Cardinali</surname><given-names>DP</given-names></name> <name><surname>Marcos</surname><given-names>A</given-names></name> <name><surname>Esquifino</surname><given-names>AI</given-names></name></person-group>. <article-title>24-hour changes in circulating prolactin, follicle-stimulating hormone, luteinizing hormone, and testosterone in young male rats subjected to calorie restriction</article-title>. <source>Chronobiol Int</source>. (<year>2004</year>) <volume>21</volume>:<fpage>393</fpage>&#x2013;<lpage>404</lpage>. doi: <pub-id pub-id-type="doi">10.1081/cbi-120038607</pub-id>, PMID: <pub-id pub-id-type="pmid">15332445</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Govic</surname><given-names>A</given-names></name> <name><surname>Levay</surname><given-names>EA</given-names></name> <name><surname>Hazi</surname><given-names>A</given-names></name> <name><surname>Penman</surname><given-names>J</given-names></name> <name><surname>Kent</surname><given-names>S</given-names></name> <name><surname>Paolini</surname><given-names>AG</given-names></name></person-group>. <article-title>Alterations in male sexual behaviour, attractiveness and testosterone levels induced by an adult-onset calorie restriction regimen</article-title>. <source>Behav Brain Res</source>. (<year>2008</year>) <volume>190</volume>:<fpage>140</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2008.02.013</pub-id>, PMID: <pub-id pub-id-type="pmid">18367259</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grewall</surname><given-names>T</given-names></name> <name><surname>Mickelsen</surname><given-names>O</given-names></name> <name><surname>Hafs</surname><given-names>HD</given-names></name></person-group>. <article-title>Androgen secretion and spermatogenesis in rats following semistarvation</article-title>. <source>Proc Soc Exp Biol Med</source>. (<year>1971</year>) <volume>138</volume>:<fpage>723</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.3181/00379727-138-35976</pub-id>, PMID: <pub-id pub-id-type="pmid">5118490</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roelfsema</surname><given-names>F</given-names></name> <name><surname>Liu</surname><given-names>PY</given-names></name> <name><surname>Takahashi</surname><given-names>PY</given-names></name> <name><surname>Yang</surname><given-names>RJ</given-names></name> <name><surname>Veldhuis</surname><given-names>JD</given-names></name></person-group>. <article-title>Dynamic interactions between LH and testosterone in healthy community-dwelling men: impact of age and body composition</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2020</year>) <volume>105</volume>:<fpage>e628</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1210/clinem/dgz246</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmboe</surname><given-names>SA</given-names></name> <name><surname>Skakkeb&#x00E6;k</surname><given-names>NE</given-names></name> <name><surname>Juul</surname><given-names>A</given-names></name> <name><surname>Scheike</surname><given-names>T</given-names></name> <name><surname>Jansen</surname><given-names>TK</given-names></name> <name><surname>Linneberg</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Individual testosterone decline and future mortality risk in men</article-title>. <source>Eur J Endocrinol</source>. (<year>2018</year>) <volume>178</volume>:<fpage>123</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1530/EJE-17-0280</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pirillo</surname><given-names>A</given-names></name> <name><surname>Casula</surname><given-names>M</given-names></name> <name><surname>Olmastroni</surname><given-names>E</given-names></name></person-group>. <article-title>Global epidemiology of dyslipidaemias</article-title>. <source>Nat Rev Cardiol</source>. (<year>2021</year>) <volume>18</volume>:<fpage>689</fpage>&#x2013;<lpage>700</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41569-021-00541-4</pub-id>, PMID: <pub-id pub-id-type="pmid">33833450</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>C</given-names></name> <name><surname>Madden-Doyle</surname><given-names>L</given-names></name> <name><surname>Jayasena</surname><given-names>C</given-names></name></person-group>. <article-title>Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology</article-title>. <source>Eur J Endocrinol</source>. (<year>2024</year>) <volume>191</volume>:<fpage>R1</fpage>&#x2013;<lpage>R17</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ejendo/lvae128</pub-id>, PMID: <pub-id pub-id-type="pmid">39344641</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x0160;o&#x0161;i&#x0107;-Jurjevi&#x0107;</surname><given-names>B</given-names></name> <name><surname>L&#x00FC;tjohann</surname><given-names>D</given-names></name></person-group>. <article-title>Differences in cholesterol metabolism, hepato-intestinal aging, and hepatic endocrine milieu in rats as affected by the sex and age</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<fpage>12624</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms241612624</pub-id>, PMID: <pub-id pub-id-type="pmid">37628805</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>M</given-names></name></person-group>. <article-title>Interrelationships among HDL metabolism, aging, and atherosclerosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2009</year>) <volume>29</volume>:<fpage>1244</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.108.181438</pub-id>, PMID: <pub-id pub-id-type="pmid">19667114</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>F</given-names></name> <name><surname>Guo</surname><given-names>D</given-names></name></person-group>. <article-title>SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth</article-title>. <source>Autophagy</source>. (<year>2024</year>) <volume>20</volume>:<fpage>1183</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2023.2275501</pub-id>, PMID: <pub-id pub-id-type="pmid">37927089</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Li</surname><given-names>Y</given-names></name> <name><surname>Yang</surname><given-names>W</given-names></name> <name><surname>Xiao</surname><given-names>C</given-names></name> <name><surname>Fu</surname><given-names>S</given-names></name> <name><surname>Deng</surname><given-names>Q</given-names></name> <etal/></person-group>. <article-title>SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes</article-title>. <source>J Steroid Biochem Mol Biol</source>. (<year>2014</year>) <volume>143</volume>:<fpage>174</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.02.009</pub-id>, PMID: <pub-id pub-id-type="pmid">24565561</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y</given-names></name> <name><surname>Gong</surname><given-names>K</given-names></name> <name><surname>Xu</surname><given-names>S</given-names></name> <name><surname>Zhang</surname><given-names>F</given-names></name> <name><surname>Meng</surname><given-names>X</given-names></name> <name><surname>Han</surname><given-names>J</given-names></name></person-group>. <article-title>Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2022</year>) <volume>7</volume>:<fpage>265</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-022-01125-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35918332</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hibbitt</surname><given-names>OC</given-names></name> <name><surname>Mcneil</surname><given-names>E</given-names></name> <name><surname>Lufino</surname><given-names>MM</given-names></name> <name><surname>Seymour</surname><given-names>L</given-names></name> <name><surname>Channon</surname><given-names>K</given-names></name> <name><surname>Wade-Martins</surname><given-names>R</given-names></name></person-group>. <article-title>Long-term physiologically regulated expression of the low-density lipoprotein receptor <italic>in vivo</italic> using genomic DNA mini-gene constructs</article-title>. <source>Mol Ther</source>. (<year>2010</year>) <volume>18</volume>:<fpage>317</fpage>&#x2013;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mt.2009.249</pub-id>, PMID: <pub-id pub-id-type="pmid">19861949</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teofilovi&#x0107;</surname><given-names>A</given-names></name> <name><surname>Vratari&#x0107;</surname><given-names>M</given-names></name> <name><surname>Veli&#x010D;kovi&#x0107;</surname><given-names>N</given-names></name> <name><surname>Vojnovic Milutinovic</surname><given-names>D</given-names></name> <name><surname>Mladenovic</surname><given-names>A</given-names></name> <name><surname>Prvulovic</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Late-onset calorie restriction improves lipid metabolism and aggravates inflammation in the liver of old Wistar rats</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>:<fpage>899255</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2022.899255</pub-id>, PMID: <pub-id pub-id-type="pmid">35677539</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hajighasem</surname><given-names>A</given-names></name> <name><surname>Farzanegi</surname><given-names>P</given-names></name> <name><surname>Mazaheri</surname><given-names>Z</given-names></name> <name><surname>Naghizadeh</surname><given-names>M</given-names></name> <name><surname>Salehi</surname><given-names>G</given-names></name></person-group>. <article-title>Effects of resveratrol, exercises and their combination on Farnesoid X receptor, liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver</article-title>. <source>PeerJ</source>. (<year>2018</year>) <volume>6</volume>:<fpage>e5522</fpage>. doi: <pub-id pub-id-type="doi">10.7717/peerj.5522</pub-id>, PMID: <pub-id pub-id-type="pmid">30221089</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sokanovic</surname><given-names>SJ</given-names></name> <name><surname>Baburski</surname><given-names>AZ</given-names></name> <name><surname>Janjic</surname><given-names>MM</given-names></name> <name><surname>Stojkov</surname><given-names>NJ</given-names></name> <name><surname>Bjelic</surname><given-names>MM</given-names></name> <name><surname>Lalosevic</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>The opposing roles of nitric oxide and cGMP in the age-associated decline in rat testicular steroidogenesis</article-title>. <source>Endocrinology</source>. (<year>2013</year>) <volume>154</volume>:<fpage>3914</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2013-1307</pub-id>, PMID: <pub-id pub-id-type="pmid">23885018</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name> <name><surname>Huhtaniemi</surname><given-names>I</given-names></name> <name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group>. <article-title>Depletion and repopulation of Leydig cells in the testes of aging brown Norway rats</article-title>. <source>Endocrinology</source>. (<year>1996</year>) <volume>137</volume>:<fpage>3447</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1210/endo.137.8.8754773</pub-id>, PMID: <pub-id pub-id-type="pmid">8754773</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WJ</given-names></name> <name><surname>Yeh</surname><given-names>JY</given-names></name> <name><surname>Tsai</surname><given-names>SC</given-names></name> <name><surname>Lin</surname><given-names>H</given-names></name> <name><surname>Chiao</surname><given-names>YC</given-names></name> <name><surname>Chen</surname><given-names>JJ</given-names></name> <etal/></person-group>. <article-title>Regulation of testosterone secretion by prolactin in male rats</article-title>. <source>J Cell Biochem</source>. (<year>1999</year>) <volume>74</volume>:<fpage>111</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1097-4644(19990701)74:1%3C111::AID-JCB12%3E3.0.CO;2-I</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katovich</surname><given-names>MJ</given-names></name> <name><surname>Cameron</surname><given-names>DF</given-names></name> <name><surname>Murray</surname><given-names>FT</given-names></name> <name><surname>Gunsalus</surname><given-names>GL</given-names></name></person-group>. <article-title>Alterations of testicular function induced by hyperprolactinemia in the rat</article-title>. <source>J Androl</source>. (<year>1985</year>) <volume>6</volume>:<fpage>179</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1939-4640.1985.tb00834.x</pub-id>, PMID: <pub-id pub-id-type="pmid">4039718</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>HB</given-names></name> <name><surname>Shan</surname><given-names>LX</given-names></name> <name><surname>Monder</surname><given-names>C</given-names></name> <name><surname>Hardy</surname><given-names>MP</given-names></name></person-group>. <article-title>Suppression of endogenous corticosterone levels <italic>in vivo</italic> increases the steroidogenic capacity of purified rat Leydig cells <italic>in vitro</italic></article-title>. <source>Endocrinology</source>. (<year>1996</year>) <volume>137</volume>:<fpage>1714</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1210/endo.137.5.8612506</pub-id>, PMID: <pub-id pub-id-type="pmid">8612506</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geraghty</surname><given-names>AC</given-names></name> <name><surname>Kaufer</surname><given-names>D</given-names></name></person-group>. <article-title>Glucocorticoid regulation of reproduction</article-title>. <source>Adv Exp Med Biol</source>. (<year>2015</year>) <volume>872</volume>:<fpage>253</fpage>&#x2013;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-2895-8_11</pub-id>, PMID: <pub-id pub-id-type="pmid">26215998</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B</given-names></name> <name><surname>Golden</surname><given-names>E</given-names></name> <name><surname>Carlson</surname><given-names>OD</given-names></name> <name><surname>Egan</surname><given-names>JM</given-names></name> <name><surname>Mattson</surname><given-names>MP</given-names></name> <name><surname>Maudsley</surname><given-names>S</given-names></name></person-group>. <article-title>Caloric restriction: impact upon pituitary function and reproduction</article-title>. <source>Ageing Res Rev</source>. (<year>2008</year>) <volume>7</volume>:<fpage>209</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2008.01.002</pub-id>, PMID: <pub-id pub-id-type="pmid">18329344</pub-id></citation></ref>
<ref id="ref56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>AD</given-names></name> <name><surname>Jarak</surname><given-names>I</given-names></name> <name><surname>Morais</surname><given-names>T</given-names></name> <name><surname>Carvalho</surname><given-names>RA</given-names></name> <name><surname>Oliveira</surname><given-names>PF</given-names></name> <name><surname>Monteiro</surname><given-names>MP</given-names></name> <etal/></person-group>. <article-title>Caloric restriction alters the hormonal profile and testicular metabolome, resulting in alterations of sperm head morphology</article-title>. <source>Am J Physiol Endocrinol Metab</source>. (<year>2020</year>) <volume>318</volume>:<fpage>e33</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpendo.00355.2019</pub-id>, PMID: <pub-id pub-id-type="pmid">31770015</pub-id></citation></ref>
<ref id="ref57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>YX</given-names></name> <name><surname>Wang</surname><given-names>Z</given-names></name> <name><surname>Ren</surname><given-names>CF</given-names></name> <name><surname>Ma</surname><given-names>TV</given-names></name> <name><surname>Deng</surname><given-names>KP</given-names></name> <name><surname>Li</surname><given-names>FZ</given-names></name> <etal/></person-group>. <article-title>Effect of dietary energy restriction and subsequent compensatory feeding on testicular transcriptome in developing rams</article-title>. <source>Theriogenology</source>. (<year>2018</year>) <volume>119</volume>:<fpage>198</fpage>&#x2013;<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.theriogenology.2018.06.028</pub-id></citation></ref>
<ref id="ref58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name> <name><surname>Zhang</surname><given-names>Z</given-names></name> <name><surname>Shen</surname><given-names>WJ</given-names></name> <name><surname>Azhar</surname><given-names>S</given-names></name></person-group>. <article-title>Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones</article-title>. <source>Nutr Metab</source>. (<year>2010</year>) <volume>7</volume>:<fpage>47</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1743-7075-7-47</pub-id>, PMID: <pub-id pub-id-type="pmid">20515451</pub-id></citation></ref>
<ref id="ref59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eacker</surname><given-names>SM</given-names></name> <name><surname>Agrawal</surname><given-names>N</given-names></name> <name><surname>Qian</surname><given-names>K</given-names></name> <name><surname>Dichek</surname><given-names>LH</given-names></name> <name><surname>Gong</surname><given-names>EY</given-names></name> <name><surname>Lee</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Hormonal regulation of testicular steroid and cholesterol homeostasis</article-title>. <source>Mol Endocrinol</source>. (<year>2008</year>) <volume>22</volume>:<fpage>623</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1210/me.2006-0534</pub-id></citation></ref>
<ref id="ref60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>PG</given-names></name> <name><surname>Dombrausky</surname><given-names>LJ</given-names></name> <name><surname>Chen</surname><given-names>YD</given-names></name> <name><surname>Payne</surname><given-names>AH</given-names></name></person-group>. <article-title>Serum lipoproteins increase testosterone production in hCG-desensitized Leydig cells</article-title>. <source>Endocrinology</source>. (<year>1981</year>) <volume>109</volume>:<fpage>1790</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1210/endo-109-5-1790</pub-id>, PMID: <pub-id pub-id-type="pmid">6271543</pub-id></citation></ref>
<ref id="ref61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Travert</surname><given-names>C</given-names></name> <name><surname>Fofana</surname><given-names>M</given-names></name> <name><surname>Carreau</surname><given-names>S</given-names></name> <name><surname>Goff</surname><given-names>DL</given-names></name></person-group>. <article-title>Rat Leydig cells use apolipoprotein E depleted high density lipoprotein to regulate testosterone production</article-title>. <source>Mol Cell Biochem</source>. (<year>2000</year>) <volume>213</volume>:<fpage>51</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1023/a:1007178532236</pub-id>, PMID: <pub-id pub-id-type="pmid">11129958</pub-id></citation></ref>
<ref id="ref62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name> <name><surname>Li</surname><given-names>J</given-names></name> <name><surname>Zhou</surname><given-names>X</given-names></name> <name><surname>Guan</surname><given-names>Q</given-names></name> <name><surname>Zhao</surname><given-names>J</given-names></name> <name><surname>Gao</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Simvastatin decreases sex-hormone levels in male rats</article-title>. <source>Endocr Pract</source>. (<year>2017</year>) <volume>23</volume>:<fpage>175</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.4158/EP161274</pub-id>, <comment>OR</comment></citation></ref>
<ref id="ref63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klinefelter</surname><given-names>GR</given-names></name> <name><surname>Laskey</surname><given-names>JW</given-names></name> <name><surname>Amann</surname><given-names>RP</given-names></name></person-group>. <article-title>Statin drugs markedly inhibit testosterone production by rat Leydig cells <italic>in vitro</italic>: implications for men</article-title>. <source>Reprod Toxicol</source>. (<year>2014</year>) <volume>45</volume>:<fpage>52</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.reprotox.2013.12.010</pub-id>, PMID: <pub-id pub-id-type="pmid">24462564</pub-id></citation></ref>
<ref id="ref64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name> <name><surname>Zhai</surname><given-names>H</given-names></name> <name><surname>Huang</surname><given-names>G</given-names></name> <name><surname>Cheng</surname><given-names>J</given-names></name> <name><surname>Xia</surname><given-names>F</given-names></name> <name><surname>Zhao</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Is lower low-density lipoprotein cholesterol associated with lower androgen and erectile dysfunction in men?</article-title> <source>Nutr Metab Cardiovasc Dis</source>. (<year>2018</year>) <volume>28</volume>:<fpage>1304</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.numecd.2018.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">30459056</pub-id></citation></ref>
<ref id="ref65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baspinar</surname><given-names>O</given-names></name> <name><surname>Bayram</surname><given-names>F</given-names></name> <name><surname>Korkmaz</surname><given-names>S</given-names></name> <name><surname>Aksu</surname><given-names>M</given-names></name> <name><surname>Kocer</surname><given-names>D</given-names></name> <name><surname>Sitiki Dizder</surname><given-names>O</given-names></name> <etal/></person-group>. <article-title>The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin</article-title>. <source>J Clin Lipidol</source>. (<year>2016</year>) <volume>10</volume>:<fpage>1452</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacl.2016.09.004</pub-id></citation></ref>
<ref id="ref66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langheinrich</surname><given-names>AC</given-names></name> <name><surname>Paradowska</surname><given-names>A</given-names></name> <name><surname>Kilinski</surname><given-names>R</given-names></name> <name><surname>Kampschulte</surname><given-names>M</given-names></name> <name><surname>Steifeld</surname><given-names>K</given-names></name> <name><surname>Altinkilic</surname><given-names>B</given-names></name> <etal/></person-group>. <article-title>Mixed testicular atrophy related to atherosclerosis: first lessons from the ApoE<sup>&#x2212;/&#x2212;</sup>/LDL receptor<sup>&#x2212;/&#x2212;</sup> double knockout mouse model</article-title>. <source>Int J Androl</source>. (<year>2012</year>) <volume>35</volume>:<fpage>562</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2605.2011.01228.x</pub-id></citation></ref>
<ref id="ref67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuefeng</surname><given-names>Y</given-names></name> <name><surname>Zhiqi</surname><given-names>L</given-names></name> <name><surname>Yi</surname><given-names>C</given-names></name> <name><surname>Keyu</surname><given-names>Z</given-names></name> <name><surname>Heng</surname><given-names>W</given-names></name> <name><surname>Yuying</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>Testosterone deficiency promotes hypercholesteremia and attenuates cholesterol liver uptake via AR/PCSK9/LDLR pathways</article-title>. <source>Int J Endocrinol</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>7989751</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2022/7989751</pub-id>, PMID: <pub-id pub-id-type="pmid">35599686</pub-id></citation></ref>
</ref-list>
</back>
</article>